X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE WYETH LTD SUVEN LIFE/
WYETH LTD
 
P/E (TTM) x 17.2 27.7 62.2% View Chart
P/BV x 3.8 5.3 70.4% View Chart
Dividend Yield % 0.6 1.3 47.6%  

Financials

 SUVEN LIFE   WYETH LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
WYETH LTD
Mar-13
SUVEN LIFE/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs2511,044 24.0%   
Low Rs155818 18.9%   
Sales per share (Unadj.) Rs49.1298.6 16.5%  
Earnings per share (Unadj.) Rs9.757.2 17.0%  
Cash flow per share (Unadj.) Rs11.458.4 19.5%  
Dividends per share (Unadj.) Rs1.5017.00 8.8%  
Dividend yield (eoy) %0.71.8 40.5%  
Book value per share (Unadj.) Rs60.3249.5 24.2%  
Shares outstanding (eoy) m127.2822.72 560.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.13.1 132.4%   
Avg P/E ratio x20.916.3 128.3%  
P/CF ratio (eoy) x17.815.9 111.7%  
Price / Book Value ratio x3.43.7 90.2%  
Dividend payout %15.429.7 52.0%   
Avg Mkt Cap Rs m25,82521,157 122.1%   
No. of employees `0001.10.5 217.9%   
Total wages/salary Rs m613400 153.2%   
Avg. sales/employee Rs Th5,832.613,787.4 42.3%   
Avg. wages/employee Rs Th571.5813.0 70.3%   
Avg. net profit/employee Rs Th1,153.82,643.3 43.6%   
INCOME DATA
Net Sales Rs m6,2536,783 92.2%  
Other income Rs m233353 66.0%   
Total revenues Rs m6,4857,136 90.9%   
Gross profit Rs m1,9821,617 122.5%  
Depreciation Rs m21327 801.1%   
Interest Rs m466 841.8%   
Profit before tax Rs m1,9551,938 100.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m718632 113.6%   
Profit after tax Rs m1,2371,301 95.1%  
Gross profit margin %31.723.8 132.9%  
Effective tax rate %36.732.6 112.6%   
Net profit margin %19.819.2 103.2%  
BALANCE SHEET DATA
Current assets Rs m5,6226,984 80.5%   
Current liabilities Rs m1,1682,056 56.8%   
Net working cap to sales %71.272.6 98.1%  
Current ratio x4.83.4 141.8%  
Inventory Days Days8199 82.0%  
Debtors Days Days3624 150.1%  
Net fixed assets Rs m3,325244 1,360.9%   
Share capital Rs m127227 56.0%   
"Free" reserves Rs m7,5475,441 138.7%   
Net worth Rs m7,6745,668 135.4%   
Long term debt Rs m1425 55.6%   
Total assets Rs m9,1357,901 115.6%  
Interest coverage x43.2353.3 12.2%   
Debt to equity ratio x00 41.1%  
Sales to assets ratio x0.70.9 79.7%   
Return on assets %14.016.5 85.0%  
Return on equity %16.122.9 70.2%  
Return on capital %26.034.0 76.5%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m5,06615 33,329.6%   
Fx outflow Rs m2,0012,677 74.7%   
Net fx Rs m3,065-2,662 -115.1%   
CASH FLOW
From Operations Rs m699923 75.8%  
From Investments Rs m-6317 -1.9%  
From Financial Activity Rs m-577-481 120.0%  
Net Cashflow Rs m116759 15.3%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 0.0 7.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 30.4 120.1%  
Shareholders   37,287 21,978 169.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Nov 16, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS